NCT02172508View on ClinicalTrials.gov

Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary Rehabilitation

PHASE4TerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

March 31, 2004

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tiotropium Inhalation Capsule

DRUG

Placebo Lactose Capsule

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02172508 - Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary Rehabilitation | Biotech Hunter | Biotech Hunter